🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/08/1986 | 6,04 | 6,14 | 6,03 | 6,13 | +1,65% | 1,75% | 4.740.523 |
| 28/08/1986 | 5,93 | 6,03 | 5,90 | 6,03 | +1,79% | 2,23% | 4.666.954 |
| 27/08/1986 | 5,95 | 5,99 | 5,89 | 5,92 | -0,78% | 1,67% | 4.814.093 |
| 26/08/1986 | 5,88 | 5,99 | 5,87 | 5,97 | +1,24% | 2,03% | 6.081.754 |
| 25/08/1986 | 6,01 | 6,01 | 5,87 | 5,90 | -1,87% | 2,31% | 5.187.600 |
| 22/08/1986 | 5,99 | 6,06 | 5,99 | 6,01 | +0,22% | 1,11% | 3.802.982 |
| 21/08/1986 | 6,04 | 6,06 | 5,95 | 6,00 | -0,44% | 1,75% | 5.615.813 |
| 20/08/1986 | 6,11 | 6,12 | 6,02 | 6,02 | -1,62% | 1,63% | 5.670.518 |
| 19/08/1986 | 6,13 | 6,16 | 6,11 | 6,12 | -0,64% | 0,86% | 4.440.586 |
| 18/08/1986 | 6,13 | 6,19 | 6,10 | 6,16 | +0,87% | 1,51% | 7.356.960 |
| 15/08/1986 | 6,06 | 6,11 | 6,00 | 6,11 | +1,21% | 1,75% | 9.530.093 |
| 14/08/1986 | 5,94 | 6,08 | 5,94 | 6,04 | +1,45% | 2,23% | 7.155.115 |
| 13/08/1986 | 5,86 | 6,02 | 5,84 | 5,95 | +1,93% | 3,06% | 8.094.542 |
| 12/08/1986 | 5,80 | 5,85 | 5,76 | 5,84 | +0,80% | 1,49% | 7.368.278 |
| 11/08/1986 | 5,69 | 5,80 | 5,67 | 5,79 | +2,34% | 2,21% | 7.666.330 |
| 08/08/1986 | 5,73 | 5,75 | 5,66 | 5,66 | -1,27% | 1,51% | 2.574.936 |
| 07/08/1986 | 5,75 | 5,79 | 5,73 | 5,73 | -0,12% | 1,15% | 5.583.744 |
| 06/08/1986 | 5,70 | 5,76 | 5,69 | 5,74 | +0,70% | 1,40% | 6.223.234 |
| 05/08/1986 | 5,67 | 5,74 | 5,67 | 5,70 | +0,47% | 1,17% | 5.574.312 |
| 04/08/1986 | 5,67 | 5,74 | 5,63 | 5,67 | -0,81% | 1,87% | 5.197.032 |
| 01/08/1986 | 5,66 | 5,75 | 5,63 | 5,72 | +1,29% | 1,99% | 6.108.163 |
| 31/07/1986 | 5,57 | 5,70 | 5,57 | 5,65 | +1,19% | 2,38% | 6.379.805 |
| 30/07/1986 | 5,48 | 5,62 | 5,45 | 5,58 | +1,94% | 3,02% | 6.764.630 |
| 29/07/1986 | 5,50 | 5,52 | 5,46 | 5,47 | +0,24% | 1,09% | 4.374.562 |
| 28/07/1986 | 5,51 | 5,54 | 5,41 | 5,46 | -0,84% | 2,41% | 6.059.117 |
| 25/07/1986 | 5,51 | 5,53 | 5,46 | 5,51 | -0,12% | 1,20% | 7.698.398 |
| 24/07/1986 | 5,51 | 5,53 | 5,49 | 5,51 | -0,24% | 0,72% | 4.376.448 |
| 23/07/1986 | 5,62 | 5,64 | 5,49 | 5,53 | -1,65% | 2,59% | 7.221.139 |
| 22/07/1986 | 5,38 | 5,62 | 5,38 | 5,62 | +4,95% | 4,43% | 10.633.637 |
| 21/07/1986 | 5,36 | 5,41 | 5,33 | 5,35 | -0,98% | 1,36% | 3.318.178 |